Author

Jonathan E. Kolitz

Northwell HealthORCID 0000-0003-2700-4784Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew J. CarrolliD· 2 shared Ann‐Kathrin EisfeldiD· 2 shared Bayard L. Powell· 2 shared Deedra NicoletiD· 2 shared Krzysztof MrózekiD· 2 shared Linde A. MilesiD· 2 shared Richard Maury StoneiD· 2 shared Robert L. BowmaniD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andrew J. CarrollORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyLeukemiaPeer-reviewedJun 15, 2026

Prognostic and Therapeutic Implications of BRAF Mutations in Acute Myeloid Leukemia

Darren Lee, Yazan Abu-Shihab, Kate Plas…·Linde A. Miles

This study identifies BRAF mutations in AML, showing poor outcomes and unique co-mutation patterns, suggesting potential targeted therapies.

DOI 10.1038/s41375-026-02996-1

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJCI InsightPeer-reviewedFeb 23, 2026

PTPN11 Mutation Clonal Hierarchy in Acute Myeloid Leukemia

Sydney Fobare, Chia Sharpe, K. R. Quinn…·John C. Byrd

This study identifies PTPN11 mutations as potential initiating events in AML when paired with NPM1 mutations, revealing their co-driver role and immune diversity in patient samples.

3 citations

mousewhole-genome sequencing

𝕏 PostBluesky